Business Wire

Enigma Biomedical Group and CBD Solutions Sign Memorandum of Understanding to License Novel Investigational Tau R4 Imaging Biomarker

TORONTO--(BUSINESS WIRE)--Enigma Biomedical Group (EBG) today announced execution of an Option Agreement to license CBD Solutions’s (CBD’s) Tau R4 imaging (TR4) biomarker CBD2115 . This option is ...
Business Wire

Enigma Biomedical Group Announces Appointment of Michael Reitermann to Their Board of Directors

TORONTO--(BUSINESS WIRE)--Enigma Biomedical Group (EBG) today announced the appointment of Michael Reitermann to their Board of Directors effective December 1, 2019. Michael Reitermann’s passion for ...
Nature

Enigma Biomedical Group

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...
Financial Post

Enigma Biomedical Group and Invicro Sign a Collaboration Agreement

TORONTO — Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug ...